ArticleFrontiers in oncology2026

Clinicopathological characteristics and response to neoadjuvant chemotherapy in HER2-low hormone receptor-positive breast cancer: a retrospective cohort study.

Wanyan Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.